References
- Morris H, Wallach J. From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs. Drug Test Anal 2014; 6:614–632.
- Gray NM, Cheng BK. EP patent 0346791, Preparation of “1,2-diarylethylamines for treatment of neurotoxic injury”. EU Patent No 0346791A1. 1989, assigned to G.D. Searle & Co.
- http://www.bluelight.org/vb/threads/700834-The-Big-and-Dandy-Methoxphenidine-(MXP-2-MeO-Diphenidine)-Thread (Last accessed on August 18, 2014).
- https://www.erowid.org/experiences/subs/exp_2MeODiphenidine.shtml (Last accessed on August 18, 2014).
- Mueller DM, Duretz B, Espourteille FA, Rentsch KM. Development of a fully automated toxicological LC-MS(n) screening system in urine using online extraction with turbulent flow chromatography. Anal Bioanaly Chem 2011;400:89–100.
- http://www.eve-rave.ch/Forum/viewtopic.php?f = 106&t = 33408 (Last accessed on August 18, 2014).
- Wood DM, Davies S, Puchnarewicz M, Johnston A, Dargan PI. Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine. Eur J Clin Pharmacol 2012; 68:853–856.
- Dillon P, Copeland J, Jansen K. Patterns of use and harms associated with non-medical ketamine use. Drug Alcohol Depend 2003; 69:23–28.
- McCarron MM, Schulze BW, Thompson GA, Conder MC, Goetz WA. Acute phencyclidine intoxication: clinical patterns, complications, and treatment. Ann Emerg Med 1981; 10:290–297.
- Fujimura H, Kawai K. Pharmacological studies on diphenylalkylamine derivatives. (I). Bull Inst Chem Res Kyoto University 1961; 39:67–77.
- Baselt RC. Cocaine. In: Baselt RC, ed. Disposition of Toxic Drugs and Chemicals in Man. 9th ed. Chicago, IL: Year Book Medical Publishers; 2002:390–394.
- Preston KL, Silverman K, Schuster CR, Cone EJ. Assessment of cocaine use with quantitative urinalysis and estimation of new uses. Addiction 1997; 92:717–727.
- Morgan CJ, Muetzelfeldt L, Curran HV. Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study. Addiction 2010; 105:121–133.
- Yu WL, Cho CC, Lung PF, Hung EH, Hui JW, Chau HH, et al. Ketamine-related cholangiopathy: a retrospective study on clinical and imaging findings. Abdom Imaging 2014 Jun 17. [Epub ahead of print].
- Wang C, Zheng D, Xu J, Lam W, Yew DT. Brain damages in ketamine addicts as revealed by magnetic resonance imaging. Front Neuroanat 2013; 7:23.